KRYS icon

Krystal Biotech

17 hedge funds and large institutions have $35.5M invested in Krystal Biotech in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
4
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17.8M
KCM
2
Knoll Capital Management
Florida
$4.46M
TCP
3
Tourbillon Capital Partners
New York
$3.05M -$701K -47,112 -19%
BBA
4
Baker Bros. Advisors
New York
$2.97M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.28M +$63.5K +4,269 +3%
AG
6
Artal Group
Luxembourg
$2.23M
HCM
7
Highbridge Capital Management
New York
$1.03M -$3.43M -231,041 -77%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$542K +$542K +36,466 New
Millennium Management
9
Millennium Management
New York
$383K +$127K +8,566 +50%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$318K +$318K +21,378 New
BlackRock
11
BlackRock
New York
$194K +$83.4K +5,607 +75%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$182K +$154K +10,331 +552%
KBC Group
13
KBC Group
Belgium
$33K
Morgan Stanley
14
Morgan Stanley
New York
$18K +$18K +1,196 New
Wells Fargo
15
Wells Fargo
California
$4K +$4K +300 New
PCM
16
Prelude Capital Management
New York
$1K +$1K +100 New
TDC
17
Thompson Davis & Co
Virginia
$1K +$1K +100 New
RCM
18
RA Capital Management
Massachusetts
-$5.01M -496,071 Closed